Posted by AGORACOM-JC
at 12:13 PM on Thursday, September 21st, 2017
Advancing its River Valley PGM project to a Preliminary Economic Assessment in 2018
Project has a measured and indicated resource of 91 Mt grading 0.84 g/t Pd + Pt + Au, 0.06% Cu, and 0.02% Ni, containing 3.9 Moz PdEq (palladium equivalent)
Currently pursuing a 16,500 ft drill program to confirm and expand the newly discovered high-grade near surface resource on the northern portion of the project
Palladium prices have almost doubled since the end of 2015
Also has a portfolio of five hard-rock lithium projects in Canada
Global platinum production was approximately 5.5 Moz, and global palladium production was approximately 6.6 Moz in 2016. To put in perspective, global gold production was 99.2 Moz in 2016. The following charts show the top platinum and palladium producers in the world.Â
Canada is the fourth largest platinum (8% of global), and third largest palladium (11% of global) producer. The U.S. imports approximately 1.38 Moz of platinum (92% of its demand) and 1.92 Moz of palladium (86% of its demand) every year. The strong reliance on imports indicates the importance of PGM projects in North America.Â
Canada is the fourth largest platinum (8% of global), and third largest palladium (11% of global) producer. The U.S. imports approximately 1.38 Moz of platinum (92% of its demand) and 1.92 Moz of palladium (86% of its demand) every year. The strong reliance on imports indicates the importance of PGM projects in North America.Â
Palladium has been one of the best performing commodities in recent times as prices were up 96%, from US$500 per oz at the end of 2015, to the current price of US$980 per oz.Â
Posted by AGORACOM-JC
at 11:26 AM on Wednesday, September 20th, 2017
Could the day come where more people watch the video-game avatars of average folks than superstar NBA athletes?
Don’t laugh. The growth of esports — defined as “a multiplayer video game played competitively for spectators, typically by professional gamers†— has been nothing short of staggering.
Millions of people love to watch these top-notch players show their stuff. Sometimes, they even fill up arenas, and it’s only getting bigger and bigger every year.
The NBA joined forces with Take-Two Interactive, publisher of the NBA 2K video game series, to create a new league that will begin play in 2018, with 17 NBA franchises, including the Toronto Raptors, taking part in the inaugural season.
“It all started last February, when (NBA commissioner Adam Silver) and Strauss Zelnick (CEO of Take-Two) announced we were going to be doing the league, but even before that, we had been exploring the esports space, trying to figure out where we could fit into it,†Brendan Donohue said Monday.
Donohue, the managing director of the NBA 2K esports league, was in town to shed some light on the venture, since many of a certain age don’t have much of a clue of what it is all about, or why esports is so popular.
“It’s 5-on-5. Oftentimes, people are used to seeing video games being played 1-on-1,†Donohue said. “This actually is going to be five human beings playing five other human beings, controlling every player on the virtual court. So there will be no artificial intelligence whatsoever.
“The good thing is, several of our owners previously had and still own other teams and other titles … So we’ve had our owners that have been passionate about esports in general, so it just made logical sense for us to make the next step. The NBA has been running a league for two-quarters of a century, and then you have 2K, which is the most popular sports game amongst the major leagues. It just seemed logical for us to take a run at this.â€
In this Sept. 3 file photo, fans watch a League of Legends esports competition at the AccorHotels Arena in Paris. Christophe Simon / AFP / Getty Images
There is already a waiting list for Year 2, as other NBA teams look to join the party.
And why not? Last month, Palisade Research released an esports primer which read in part: “The Esports sector is forecasted to generate $1.13 billion (U.S.) in 2017, with 258 million viewers. By 2021, revenue is expected to grow to $2.70 billion, and to 438 million viewers. Some analysts peg revenues to reach as high as $3.31 billion, which would almost match the revenues of the established National Hockey League ($3.7 billion), and on the heels of the National Basketball Association ($4.8 billion).â€
Donohue said he has heard those projections, but right now, the focus is on “just wanting to be the best possible.â€
He is well aware of how the financial world feels about esports, though.
“For example, you look at something like Twitch, which has 10 million daily viewers,†Donohue said. “Goldman Sachs has looked at it and I’ve seen their reports — they predict it will be 20 million (daily viewers) by 2020. Everyone who is looking at this is predicting both viewership and revenues to continue to explode in the near future.â€
Donohue knew Maple Leaf Sports and Entertainment wouldn’t sit on the sidelines.
“I’ve known the folks at MLSE for a long period of time,†he said. “They are extremely innovative, they are very digitally savvy, they are a great organization and I know they are passionate about this space, so I assumed they were going to be in.â€
Could the NHL follow in the NBA’s footsteps in getting into esports in a major way?
It could happen down the line considering the massive financial potential. Washington Capitals and Wizards owner Ted Leonsis is already heavily involved, and MLSE, Madison Square Garden (New York Knicks and Rangers) and Joshua Harris (Philadelphia 76ers and New Jersey Devils), three of the 17 initial NBA participants, also own NHL franchises.
In this March 1 file photo, Toronto Raptors forward Serge Ibaka (centre) drives to the hoop against the Washington Wizards. Chris Young / CP
MLSE declined to comment on Monday about a potential Maple Leafs esports franchise.
At a business summit back in March, NHL commissioner Gary Bettman said, “We envision something that would augment a fan’s affinity to his team … because, ultimately, I could envision a league-wide competition where each club runs a competition to see who will be represented in the equivalent of our championship, but for our esport game.â€
At the time, Bettman said the NHL had been discussing the idea for over a year, “and if (NHL video game maker Electronic Arts) can continue to get some traction in developing a game that would work like that, we’ll be in that business.â€
Which would be no surprise at all to Donohue.
“I would expect other leagues to follow our lead and to get involved in this. I would expect that to happen. I think it’s great for esports,†he said.
“Other (professional league) games being successful just continues to grow the broader universe.â€
ONLY THE BEST
The players for the new NBA 2K esports league will come from all over.
“Our goal, to make this the best league possible, is to find the best 85 players on the planet. They can be anywhere in the world, they can be male, they can be female — we just want the best 85 players,†league managing director Brendan Donohue told Postmedia on Monday.
Players will be paid by their respective teams. Tryouts will start around Feb. 1, 2018, with a draft to follow in mid-March. The season will run from May 1 and go for 15 weeks, before concluding with two weeks of playoffs ending the third week of August.
When most people think esports, if they know anything about the phenomenon in the first place, they picture teenagers and people in their early 20s playing video games. Donohue said NBA 2K players don’t really fit that description.
“We actually don’t skew that young. So, 58 per cent of our player are actually over 25, so we skew a little older,†he said. “I think there are some myths about our players in general. They’re actually more likely to be educated, more likely to have a higher income. There are some myths out there about esports.â€
For the first season, the 17 teams will play “in a central studio, or maybe two, somewhere in North America,†Donohue said.
Games won’t be played in sold-out arenas just yet, but that could happen down the line.
“We’re excited to be in Toronto (long-term),†Donohue said. “When they’ve had esports events (at the Air Canada Centre) before they’ve been very successful. We see this as a great market.â€
Posted by AGORACOM-JC
at 9:49 AM on Wednesday, September 20th, 2017
Signed a Product Acquisition Agreement with Aphria Inc. (TSX:APH) (OTCQB:APHQF), to supply medical cannabis through Namaste’s Cannmart facility in Ontario, Canada
Agreement represents further progress for Namaste in securing supply agreements with high quality producers of medical cannabis
VANCOUVER, British Columbia, Sept. 20, 2017 — Namaste Technologies Inc. (“Namaste†or the “Companyâ€) (CSE:N) (FRANKFURT:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that it has signed a Product Acquisition Agreement (the “Agreementâ€) with Aphria Inc. (“Aphriaâ€) (TSX:APH) (OTCQB:APHQF), to supply medical cannabis through Namaste’s Cannmart facility in Ontario, Canada.
The Agreement represents further progress for Namaste in securing supply agreements with high quality producers of medical cannabis. Namaste intends to build on its current product offerings through its distribution license, by creating an online marketplace that is inclusive of medical cannabis for our Canadian customers. Namaste is pleased to have brought on Aphria, one of Canada’s leading licensed producers focused on production of pharmaceutical grade medical cannabis products.
About Aphria Inc.
Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada, Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. It is committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. It is the first public licensed producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters.
Management Commentary
Sean Dollinger, President and CEO of Namaste comments: “We are very pleased to be working with Aphria, who we believe to be one of the top Canadian producers of the highest quality medical cannabis products. Our goal is to create an online marketplace for our patients that will offer a variety of products sourced from various producers in Canada and overseas. We plan to leverage our existing database of Canadian consumers along with our expertise in e-commerce to provide a unique platform for medical patients to access. We are excited to offer Aphria product to our Cannmart patients shipped from our facility in Toronto, Ontario.â€
Namaste Technologies Inc. is an emerging leader in vaporizer and accessories space. Namaste has 26 ecommerce retail stores in 20 countries, offers the largest range of brand name vaporizers products on the market and is actively manufacturing and launching multiple unique proprietary products for retail and wholesale distribution. The Company is currently focused on expanding its product offering, acquisitions and strategic partnerships, and entering new markets globally.
FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.
Posted by AGORACOM
at 9:28 AM on Tuesday, September 19th, 2017
Located 20 kilometres northwest of Bathurst
Multiple pathfinder minerals located ( gold, silver, zinc, lead and / or copper occurrences )
500 metre drill program to test multiple base metal and silver bearing vein occurrences
Vancouver, British Columbia (FSCwire) – GREAT ATLANTIC RESOURCES CORP. (TSXV.GR) (the “Company†or “Great Atlanticâ€) is pleased to announce it has received a diamond drilling permit from the New Brunswick Dept. of Energy and Mines for its Keymet Precious – Base Metal Property, located in northeast New Brunswick. The Company is planning drilling beginning in mid-September in the northwest region of the property. The Keymet property, located approximately 20 kilometres northwest of Bathurst, hosts multiple gold, silver, zinc, lead and / or copper occurrences including the Keymet deposit, site of the historic Keymet Mine. Drilling will further test an area of reported zinc, lead, copper and silver bearing vein(s) including 2015 Great Atlantic drill intersections (16.7 % zinc and 152 g/t silver over 1.8 meter core length and 8.7% zinc over 4.28 meter core length) and a near-by gold bearing zone discovered by the Company in a 2015 trench (1.1 g/t gold over 4.9 meters in channel sampling).
To view the graphic in its original size, please click here
The drilling program is planned for the northwest region of the Keymet Property, a priority area for the Company. The program will be a minimum of 500 metres. Multiple base metal and silver bearing vein occurrences are reported in this region, including the historic Keymet Mine which operated during the 1950s. The drilling program will further test one of these vein occurrences, referred to as the Elmtree 12 vein occurrences. Gold bearing boulders and gold bearing zones in trench bedrock are also documented in this region of the property. The drilling program will test one such gold zone.
Historic Keymet Mine (1950s)
To view the graphic in its original size, please click here
The Elmtree 12 base metal and silver bearing vein occurrence is located approximately 1.4 kilometres northwest of the historic Keymet Mine. Closed-spaced 1980s diamond drill holes (Brunswick Mining and Smelting and Aurtec Inc.) intersected near-surface mineralized veins in this area. A 0.88 metre core length interval from a 1981 drill hole was reported to grade 7.72% Cu, 11.36% Zn and 13.6 ounces per ton Ag. A 1.22 metre core length sample from a near-by 1989 drill hole was reported to assay 16.4% Cu, 10.11% Zn and 31.0 ounces per ton Ag. The true width of these intersections is unknown. These drill intersections are within 50 metre vertical depth. During 2015, Great Atlantic conducted trenching in the area of these reported 1980s drill holes. One trench exposed a northwest striking mineralized vein approximately above the reported 1980s drill intersections. A 0.5 metre channel samples across the vein returned 1.52% zinc, 1.94% copper and 308 g/t silver.
During 2015 Great Atlantic drilled two holes (Ky-15-3 and Ky-15-4) in the area of the 2015 trench and the 1980s holes. These holes were also collared within a zone of gold bearing silicified sedimentary boulders previously discovered by the Company (boulder assays reported up to 51 grams per tonne Au.). The zone of gold-bearing boulders extends west of these two holes in the reported up-ice glacial direction. Both holes intersected base metal and silver bearing veins and local gold mineralization.
Zinc, copper and silver bearing vein in 2015 Trench at Elmtree 12 Vein Occurrence
To view the graphic in its original size, please click here
Both Ky-15-3 and Ky-15-4 were drilled from the same set-up to the northeast (050 degree azimuth) approximately under the previous 2015 trench and from the opposite direction as the reported 1980s holes. Ky-15-3 was drilled at a 45 degree angle and intersected sphalerite – rich veins at 60.80 – 62.60 metres (returning 16.68% zinc, 1.11% copper and 152.0 g/t silver over a 1.80 metre core length). Ky-15-4 was drilled at a 60 degree dip on the same azimuth to intersect the veins deeper. Multiple sphalerite bearing veins were intersected in this hole at 90.07 – 94.35 metres (returning 8.68% zinc and 44.8 g/t silver Ag over 4.28 metre core length), approximately 35 metres vertically under the main vein intersected in Ky-15-3. Hole Ky-15-3 intersected a gold bearing interval, with a sample at 30.10 – 32.20 meters (2.1 meter core length) returning 3.28 g/t gold. The true width of these initial 2015 drill intersections is unknown at this time.
Drilling is planned during September 2017 on either side of holes Ky-15-3 and Ky-15-4 testing the continuation of the zinc, copper and silver bearing veins along strike and testing the continuation of the gold bearing zone intersected in Ky-15-3.
Drilling is also planned during the September program under a gold bearing zone exposed during a 2015 trench southwest of holes Ky-15-3 and Ky-15-4. Channel samples from a zone of altered sediments returned 1.11 g/t gold over a 4.9 metre total length. The channel samples were orientated east-west parallel to the trench direction. The orientation of this gold bearing zone has not been determined. This gold bearing zone is approximately 80 metres southwest of the collars of holes Ky-15-3 and Ky-15-4.
Zinc (sphalerite) – bearing carbonate vein in Ky-15-4.
To view the graphic in its original size, please click here
Access to the property is excellent with paved roads transecting the property, including a provincial highway. The property covers an area of approximately 3,400 hectares.
Readers are warned that historical records referred to in this News Release have been examined but not verified by a qualified person. Further work is required to verify that historical assays referred to in this News Release are accurate.
David Martin, P.Geo., a Qualified Person as defined by NI 43-101, is responsible for the technical information contained in this News Release.
About Great Atlantic Resources Corp.: Great Atlantic Resources Corp. is a Canadian exploration company focused on the discovery and development of mineral assets in the resource-rich and sovereign risk-free realm of Atlantic Canada, one of the number one mining regions of the world. Great Atlantic is currently surging forward building the company utilizing a Project Generation model, with a special focus on the most critical elements on the planet that are prominent in Atlantic Canada, Antimony, Tungsten and Gold.
On Behalf of the board of directors
“Lorne Mannâ€
This press release includes certain statements that may be deemed “forward-looking statementsâ€. All statements in this release, other than statements of historical facts, that address future exploration drilling, exploration activities and events or developments that the Company expects, are forward looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include exploitation and exploration successes, continued availability of financing, and general economic, market or business conditions.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Great Atlantic Resource Corp
888 Dunsmuir Street – Suite 888, Vancouver, B.C., V6C 3K4
Posted by AGORACOM-JC
at 7:40 AM on Tuesday, September 19th, 2017
Advanced, second stage bench testing program is about to commence
Gen 2 PUREVAPtmQuartz Reduction Reactor (“QRR”) reactor, 1/250 scale model of the planned 200 tonnes per annum (tpa) Pilot Plant will be operational in the coming weeks
MONTREAL, QUEBEC–(Sept. 19, 2017) –HPQ Silicon Resources Inc(“HPQ”) (TSX VENTURE:HPQ)(FRANKFURT:UGE)(OTC PINK:URAGF)Â is pleased to advise shareholders that an advanced, second stage bench testing program is about to commence. PyroGenesis Canada Inc (PyroGenesis) has informed HPQ that the Gen 2 PUREVAPtmQuartz Reduction Reactor (“QRR”) reactor, 1/250 scale model of the planned 200 tonnes per annum (tpa) Pilot Plant will be operational in the coming weeks.
Bernard J. Tourillon, Chairman and CEO of HPQ Silicon stated, “The design and construction of the Gen 2 PUREVAPtmQRR is another exciting step toward commercialization and is a result of the collaborative efforts of PyroGenesis and HPQ. Building on our success to date the Gen 2 PUREVAPtmQRR will allow for further refinements to the silicon purification and testing of the numerous process improvements now planned for the Pilot Plant. This will greatly de-risk our project and provide valuable information sooner as we continue to make the process adjustments needed to produce Solar Grade Silicon Metal.”
GEN 1 PUREVAPtmQRR REACTOR: SUCCESSFUL AND NOW BEING RETIRED
The first generation batch lab scale PUREVAPtmQRR (now referred to as Gen 1 PUREVAPtm) was built to prove the concept that quartz could be transformed in one step into Silicon Metal (Si), for the solar panel industry. A series of tests using the Gen 1 PUREVAPtm were ordered (September 2, 2016 PR) to generate key technical data required for the design of the 200 tpa pilot plant capable of producing Solar Grade Si (SoG Si). The Gen 1 PUREVAPtm process succeeded, demonstrating significant impurity removal, in one step, transforming low purity SiO2(Quartz) into 3N+ Purity Si (99.97% Si) (May 16, 2017 PR, January 26, 2017 PR, November 29, 2016 PR, November 2, 2016 PR and September 29, 2016 PR). This product exceeds the highest purity level of the Metallurgical Grade Silicon Metal (Mg Si) industry, a US$5.5 billion dollar per year industry1.
1
Source CRU, 2018 MG Si demand projected at 2,5 M tonnes, 2018 prices US$2,200 per tonne (Ferroglobe)
Our next key milestone is to produce quantities of solar grade silicon for testing of its electrical characteristics, sending material to industry participants and finalize Pilot plant design en route to commercialization. CEO Bernard Tourillon commented, “Our Gen 1 PUREVAPtmwas a great success and we believe the reactor will eventually make its way to a science and engineering hall of fame. It has currently reached its maximum operational efficiencies and nothing more could be gained by additional tests.”
GEN 2 PUREVAPtmQRR REACTORPRESENTS MAJOR DE-RISKING MILESTONES
The Gen 2 Purevapâ„¢ QRR will focus on Process Refinement, Characterization, Metallurgical Testing and purity improvements using the new semi-continuous feed 1/250 scale pilot-plant (May 4, 2017, PR).
Based on Gen 1 PUREVAPtm results, PyroGenesis completed the detailed engineering and design of the 200 tpa pilot plant, including substantial process modifications. Gen 2 PUREVAPtm therefore is an upgraded version of the Gen 1 Purevaptm that will be a true 1/250 scale replica of the planned larger pilot plant (Gen 3 PUREVAPtm). The Gen 2 PUREVAPtm is undergoing final manufacturing, assembly and testing and will be operational during the first weeks of October 2017.
The start of this new metallurgical testing program using The Gen 2 PUREVAPtm represents major de-risking of the Pilot Plant program for the following reasons:
Gen 2 will allow specific process design improvements and modifications derived from Gen 1 PUREVAPtm test work to be implemented and perfected;
The Gen 2 produces larger silicon Metal (Si) samples to test improvements to the purification process;
Gen 2 allows an intermediate step in scaling up to the Pilot Plant, mitigating that scaling up risk;
Gen 2 will allow the following Milestones to be reached sooner than originally planned;
Producing larger Si samples for testing by potential purchasers;
Allows HPQ and Pyrogenesis to test the electrical parameters of the High Purity Si;
Produce enough material to send samples to Solar industry participants;
Provide data to demonstrate the economics of PUREVAPâ„¢ QRR.
PYROGENESIS CEO REMARKS
“We are pleased to join HPQ in announcing both reaching this new milestone and commencing the second stage testing program,” said P. Peter Pascali, President and CEO of PyroGenesis. “I also wish to commend the team, both at PyroGenesis and HPQ, for having persevered through the many challenges to date and for all the discoveries they made along the way (the ability to transform low purity Quartz into 3N+ Silicon Metal in one step at lab scale not being the least of them). As we have said in the past, it will not be a straight line to success, but given the results to date we are more confident then ever before that we will have a commercial success. What level of success, is yet to be determined. As in all projects, delays will occur, but I firmly believe we are on the right track to have a significant impact in the high purity silicon and solar markets.”
UPDATE ON SILICON METAL PURITY TESTING
Further to our June 23, 2017 press release, the company continued to work with PyroGenesis and a number of specialized laboratories on silicon analysis protocols. Specifically, efforts focus on analytical procedures, certification, and analysis turn around time. We are working with our partners to resolve the analytical bottlenecks.
Results will be reported in a comprehensive report on the proof of concept and phase one process characterization and metallurgical testing programs, being prepared by PyroGenesis.
This Press Release Is Available On The Company’s CEO Verified Discussion Forum, A Moderated Social Media Platform That Enables Civilized Discussion and Q&A Between Management and Shareholders.
HPQ Silicon Resources Incis a TSX-V listed resource company planning to become a vertically integrated and diversified Metallurgical Grade and Solar Grade Silicon Metal producer.
Our business model is focused on developing a disruptive one step High Purity and Solar Grade Silicon Metal manufacturing process (patent pending). HPQ plans to generate high yield returns and significant free cash flow within a relatively short time line. The process will have a greatly decreased carbon footprint, energy footprint, and will eliminate the use of the toxic chemical reagents and by products now in use by the current solar silicon production technologies, which fundamentally date from designs made in the mid 1900’s.
Disclaimers:
This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the securities regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 4:17 PM on Monday, September 18th, 2017
New index comprised of the securities of the largest companies trading on the exchange
CSE25 Index is a subgroup of the CSE Composite Index
Toronto, Ontario–(September 18, 2017) – The Canadian Securities Exchange (“CSE”) is pleased to announce the introduction of a new index comprised of the securities of the largest companies trading on the exchange.
The CSE25 Index is a subgroup of the CSE Composite Index. The composite index launched in 2015 and includes almost half of the exchange’s listed companies and covers over 75% of the trading activity on the exchange. The new index includes the top twenty-five securities by market capitalization contained in the composite index. These companies account for over 50% of the weighting in the larger index and are typically stocks that attract considerable trading volume.
Richard Carleton, CEO, observed that “as the exchange has grown rapidly in terms of trading volumes and market capitalization it is appropriate that we give market participants a benchmark that monitors the performance of our largest and most liquid issues. As the ‘exchange for entrepreneurs’ we are proud of their success in the Canadian capital markets.”
Trading volumes on the CSE have been exceptionally robust in 2016 and 2017. The turnover of the entire market measured by the value of trading divided by the total market cap has averaged 6.6% per month in the year to date, which represents a level of market activity unrivalled in the Canadian exchange space.
A complete list of the constituent securities of the CSE25 Index appears below.
Symbol
Security Name
CSE 25
Weighting
LHS
Liberty Health Sciences Inc.
14.31%
TRST
CannTrust Holdings Inc.
13.00%
URB.A
Urbana Corporation A NV
6.25%
AHG
Alternate Health Corp.
5.69%
MARI
Maricann Group Inc
5.13%
CRZ
CannaRoyalty Corp.
4.90%
BCC
The Canadian Bioceutical Corporation
4.11%
MDM
Marapharm Ventures Inc
3.96%
URG
Oriental Non-Ferrous Resources Development Corp.
3.68%
GLH
Golden Leaf Holdings Ltd.
3.56%
XMG
MGX Minerals Inc.
3.13%
FLT
Drone Delivery Canada Corp.
2.99%
THC
THC Biomed Intl Ltd
2.88%
ISOL
Isodiol International Inc.
2.82%
IN
InMed Pharmaceuticals Inc.
2.76%
BLO
Cannabix Technologies Inc.
2.54%
N
Namaste Technologies Inc.
2.22%
IAN
iAnthus Capital Holdings Inc.
2.22%
VGW
Valens Groworks Corp.
2.22%
MTA
Metalla Royalty and Streaming Ltd.
2.15%
SNA
Star Navigation Systems Group Ltd.
2.02%
LDS
Lifestyle Delivery Systems Inc
1.95%
MYM
MYM Nutraceuticals Inc.
1.91%
MRM
Micromem Technologies Inc.
1.81%
RSS
RESAAS Services Inc.
1.80%
About the CSE
The Canadian Securities Exchange is home to more than 300 uniquely listed issues covering a broad range of industry sectors. The exchange provides trade execution, smart routing, risk management, compliance and market information services for Canadian listed instruments.
Recognized as an exchange by the Ontario Securities Commission in 2004, the CSE is designed to facilitate the capital formation process for public companies through a streamlined approach to company regulation that emphasizes disclosure and the provision of efficient secondary market trading services for investors.
Posted by AGORACOM-JC
at 8:17 AM on Monday, September 18th, 2017
Announced that it will be filing a clinical trial application in the coming weeks to therapeutic products directorateÂ
Purpose to initiate its Phase 3 clinical trial of PPP001 in terminal cancer patients
With this filing, Tetra expects to be on time with its previously announced schedule with the development of PPP001
OTTAWA, ONTARIO–(Sept. 18, 2017) –Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(OTCQB:TBPMF), today announces that it will be filing a clinical trial application (CTA) in the coming weeks to therapeutic products directorate (TPD) to initiate its Phase 3 clinical trial of PPP001 in terminal cancer patients. With this filing, Tetra expects to be on time with its previously announced schedule with the development of PPP001. The corporation worked with physicians of Sante Cannabis to design a clinical trial that would demonstrate the safety and efficacy of PPP001 in terminal cancer patients. In addition, as part of the clinical trial, Tetra will collect the pharmacoeconomics evidence required from provincial insurers in order to support the reimbursement of the first cannabis prescription drug.
A significant percentage of patients placed on a cannabis treatment suffer from side effects that are not tolerable. This can lead to patients stopping a potentially effective therapy. As part of its early phase clinical research, Tetra developed dosing strategies to minimize moderate and severe side effects in patients. This dosing strategy was developed in healthy volunteers over the last few months and has shown to be effective in reducing the severity of the side effects and preventing certain serious ones. This allows TBP to initiate its Phase 3 trial based on clinical data proposing a more tolerable approach to consuming smoked cannabis and to assess PPP001 in terminal cancer patients. This is a significant step in the development of a safe, tolerable and effective new drug for the management of chronic pain in terminal cancer patients with co-morbidities.
This will be the first Phase 3 clinical trial studying the therapeutic benefits of a smoked dried cannabis prescription drug in terminal cancer patients. Due to the status of cannabis under the Controlled Drugs and Substances Act in Canada, over the last four months the corporation developed procedures and methods that would both satisfy the Narcotic Controls Regulations and ensure the protection of patients consuming the cannabis. The corporation is confident that these procedures will be well received by Health Canada as they ensure compliance with both the Food and Drug Act and Controlled Drugs and Substances Act.
Tetra also reports that it has restructured its investors and public relation functions to integrate them with the marketing and communication functions. Mr. Edward Miller is leaving the Corporation effective as of today. We want to thank Mr. Miller for the work he has done for the Corporation over the last months and wish him all the success he deserves for his new professional projects.
About PPP001:
PPP001 aims to be the first smokable marihuana for advanced cancer pain under prescription. It is a dried cannabis pellet designed to be smoked in an inhalation device specifically developed for this product.
Tetra Bio-Pharma (TSX VENTURE:TBP)(OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra has three core expertise: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based drugs.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Source: Tetra Bio-Pharma
Tetra Bio-Pharma Inc.
Anne-Sophie Courtois
Vice- President Marketing & Communication
(514) 360 8040 Ext. 210 [email protected]
www.tetrabiopharma.com
Posted by AGORACOM-JC
at 4:58 PM on Friday, September 15th, 2017
A wholly owned subsidiary of
Augusta Industries Inc.
Engaged in the development, design, manufacture and supply of systems using fiber optic sensors, related monitoring instruments, and software
Clients include Enbridge and The Pembina Institute
Marcon’s major clients include Saudi Arabia-Sabic Services (Refining and Petrochemical), Bahrain National Gas Co, Bahrain Petroleum, Qatar Petroleum, Qatar Gas, Qatar Petrochemical, Gulf of Suez Petroleum, Agiba Petroleum and Burullus Gas Co
Provides support engineering services related to planning, training, on-site installation, and data interpretation and reporting.
CLIENTS INCLUDE
FOX-TEK’s systems serve the needs of the oil and gas, power generation, chemical, mining, and civil structure market sectors, worldwide.
Systems can be configured to operate continuously or on an inspection basis.
They can also be monitored remotely
Oil And Gas
Mining
Sensors measure displacement to add value in the areas of critical operations, safety, environmental protection, improved maintenance, and extended lifetime.
Systems are built on proven components and know-how in the areas of telecommunications based fiber optics, electronics and optics, and control and signal processing software.
Involved in the industrial supply of equipment and parts procuring for its clients which are principally clients in the oil and gas industry and United States government agencies such as the Department of Defense, Department of the Interior, Department of Homeland Security and Department of Agriculture.
Provides procurement and support services to existing and new projects worldwide in the energy sector. Initially the company had focused on providing services in the energy sector but moved on to government contracts and government services.
Marcon has two subsidiaries, Marcon USA and Marcon UK, to help enhance and support its logistic and sales operations
Servicing the energy sector and a number of US Government entities. Marcon’s principal business is the sale and distribution of industrial machinery and equipment such as cranes, derricks, diesel engines, conveyor systems, oil refining machines, packing machinery, industrial pumps and welding machinery.
In addition to departments and agencies of the U.S. Government, Marcon’s major clients include Saudi Arabia-Sabic Services (Refining and Petrochemical), Bahrain National Gas Co, Bahrain Petroleum, Qatar Petroleum, Qatar Gas, Qatar Petrochemical, Gulf of Suez Petroleum, Agiba Petroleum and Burullus Gas Co.
